Bipolar affective disorder: A review of novel forms of therapy

1. Amrollahi Z. et al.: Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J. Affect. Disord., 129, 327, 2011.Search in Google Scholar

2. Anand A. et al.: Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial. Bipolar Disord., 14, 64, 2012.10.1111/j.1399-5618.2011.00971.x22329473Search in Google Scholar

3. Berk M. et al.: Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial. Berk et al. BMC Med., 10, 91, 2012.10.1186/1741-7015-10-91348258022891797Search in Google Scholar

4. Berk M. et al.: The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial. J. Affect. Disord., 135, 389, 2011.10.1016/j.jad.2011.06.00521719110Search in Google Scholar

5. Dell’Osso B. et al.: Superior chronic tolerability of adjunctive modafinil compared to pramipexole in treatment-resistant bipolar disorder. J. Affect. Disord., 150, 130, 2013.10.1016/j.jad.2012.11.03023261131Search in Google Scholar

6. Fan A. et al.: Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study. Bipolar Disord., 14, 206, 2012.10.1111/j.1399-5618.2012.01001.x22420596Search in Google Scholar

7. Gao Y. et al.: Memantine reduces mania-like symptoms in animal models. Psychiatry Res., 188, 366, 2011.10.1016/j.psychres.2010.12.03021269711Search in Google Scholar

8. Ionescu D.F. et al.: A single infusion of ketamine improves depression scores in patients with anxious bipolar depression. Bipolar Disord., 17(4), 438, 2015, doi: 10.1111/bdi.12277.10.1111/bdi.12277443195525400146Search in Google Scholar

9. Jahangard L. et al.: In a double-blind, randomized and placebocontrolled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder; Eur. Neuropsychopharmacol., 24, 1210, 2014.Search in Google Scholar

10. Koukopoulos A. et al.: The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: Findings from a 12-month naturalistic trial; J. Affect. Disord., 136, 163, 2012.10.1016/j.jad.2011.09.04022030128Search in Google Scholar

11. Kulkarnia J. et al.: A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania; Psychoneuroendocrino., 43, 52, 2014.10.1016/j.psyneuen.2014.02.00424703170Search in Google Scholar

12. Lally N. et al.: Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression; Transl. Psychiatry, 4, e469; doi:10.1038/tp.2014.10, 2014.10.1038/tp.2014.10396603824643163Search in Google Scholar

13. Magalhaes P.V. et al.: N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial; J. Affect. Disord., 129, 317, 2011.10.1016/j.jad.2010.08.00120800897Search in Google Scholar

14. Nguyen T.V. et al.: Hormonal Treatments for Bipolar Disorder: A Review of the Literature; Journal of Behavioral and Brain Science, 2, 48, 2012.10.4236/jbbs.2012.21006Search in Google Scholar

15. Niemegers P. et al.: Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression; Expert Opin. Drug Metab. Toxicol., 8(9), 1189, 2012.10.1517/17425255.2012.70833822803602Search in Google Scholar

16. Permoda-Osip A. et al.: Factors connected with efficacy of single ketamine infusion in bipolar depression; Psychiatr. Pol., 48, 35, 2014.10.12740/PP/21175Search in Google Scholar

17. Savitz J. et al.: Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, doubleblind, placebo-controlled, 2x2 clinical trial; BMJ Open, 2, e000643, 2011.10.1136/bmjopen-2011-000643328999022357572Search in Google Scholar

18. Sienaert P. et al.: Evidence-based treatment strategies for treatmentresistant bipolar depression: a systematic review; Bipolar Disord., 15, 61, 2013.10.1111/bdi.1202623190379Search in Google Scholar

19. Stanley I.: Lithium and the Other Mood Stabilizers Effective in Bipolar Disorder Target the Rat Brain Arachidonic Acid Cascade; ACS Chem. Neurosci., 5, 459, 2014.10.1021/cn500058v406350424786695Search in Google Scholar

20. Stertz L., Magalha P.V.S., Kapczinski F.: Is bipolar disorder an inflammatory condition? The relevance of microglial activation; Curr. Opin. Psychiatry, 26,19, 2013.Search in Google Scholar

21. Weiser M. et al.: Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder; Bipolar Disord., 16, 441, 201410.1111/bdi.1220224712840Search in Google Scholar